Stakeholder meeting on HIV/AIDS

03 September 2013 - 04 September 2013
Lisbon, Portugal
Type of event EDCTP stakeholder meeting
Scope HIV

The objectives of the stakeholder meeting on HIV/AIDS were to:

  • Review the current status in the field of HIV/AIDS
  • Identify the key research areas, current opportunities and barriers to progress.

Participants at the meeting included researchers from academia, representatives of product development partnerships (PDPs) and pharmaceutical industry, policy makers, funding agencies and other like-minded organisations.

Amongst the topics to be discussed are:

  • Building partnerships to conduct large scale Phase III and IV trials
  • Adult and paediatric treatment (clinical management, drug development and reformulation of existing drugs)
  • Evaluating the impact of interventions on co-morbidities/coinfections, and on development of antiretroviral resistance
  • HIV prevention research with new and existing tools
  • Most-at-risk populations (MARPs)
  • Capitalising on EDCTP investment in capacity strengthening and trial site requirements for conducting HIV clinical trials

Expected outcomes of the meeting
A meeting report including recommendations will be produced and published on the EDCTP website. The report will also include results from the online consultation.

The final recommendations are expected to contribute towards the EDCTP strategy for supporting the HIV/AIDS research on:

  • Priority research topics for calls for proposals
  • Proposals for development of cooperative projects
  • Products in the pipeline for evaluation by EDCTP
  • Focused capacity building initiatives
  • Proposals for funding partnerships

Background reading material

  1. UNAIDS global report 2012
  2. PEPFAR blueprint: creating an AIDS-free generation
  3. EDCTP HIV/AIDS portfolio



  • Professor Charles Mgone, EDCTP Executive Director, The Netherlands
    Plans and Progress towards EDCTP2

    Download PDF
  • Professor Gita Ramjee, MRC South Africa
    HIV overview

    Download PDF
  • Dr Paula Munderi, MRC/UVRI Research Unit on AIDS, Uganda
    Treatment and Care I: Product portfolio

    Download PDF
  • Professor Philippe Van de Perre, University of Montpellier, France
    Treatment and Care II: Paediatrics, PMTCT

    Download PDF
  • Professor Linda-Gail Bekker, Desmond Tutu HIV Centre, South Africa
    Treatment and care III: Implementation research

    Download PDF
  • Professor Pontiano Kaleebu, MRC/UVRI Uganda Research Unit, Uganda
    Vaccines (preventive and therapeutic): Product portfolio

    Download PDF
  • Professor Sheena McCormack, MRC Clinical Trials Unit, UK
    Prevention: Product portfolio, microbicides, PrEP

    Download PDF